{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:12:49Z","timestamp":1792548769997,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-CA14089"],"award-info":[{"award-number":["P30-CA14089"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35-CA197461"],"award-info":[{"award-number":["R35-CA197461"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1245\/s10434-022-12595-w","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T13:04:03Z","timestamp":1664197443000},"page":"1017-1025","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients"],"prefix":"10.1245","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-3507","authenticated-orcid":false,"given":"Julie O.","family":"Culver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Freiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charit\u00e9","family":"Ricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob G.","family":"Comeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmeline Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duveen","family":"Sturgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josie","family":"Kagey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana G.","family":"Dobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Terando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"12595_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","volume":"34","author":"CD Runowicz","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol. 2016;34:611\u201335.","journal-title":"J Clin Oncol."},{"key":"12595_CR2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jama.2019.10987","volume":"322","author":"DK Owens","year":"2019","unstructured":"Owens DK, Davidson KW, Krist AH, et al. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322:652\u201365.","journal-title":"JAMA."},{"key":"12595_CR3","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"26","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, et al. consensus guidelines on genetic testing for hereditary breast cancer from the American Society of Breast Surgeons. Ann Surg Oncol. 2019;26:3025\u201331.","journal-title":"Ann Surg Oncol."},{"key":"12595_CR4","first-page":"e143-9","volume":"134","author":"American College of Obstetricians and Gynecologists","year":"2019","unstructured":"American College of Obstetricians and Gynecologists. Hereditary cancer syndromes and risk assessment: ACOG committee opinion, no. 793. Obstet Gynecol. 2019;134:e143-9.","journal-title":"Obstet Gynecol."},{"key":"12595_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","volume":"19","author":"MB Daly","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, et al. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2021;19:77\u2013102.","journal-title":"J Natl Compr Cancer Netw."},{"key":"12595_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/COC.0000000000000073","volume":"39","author":"A Stuckey","year":"2016","unstructured":"Stuckey A, Febbraro T, Laprise J, Wilbur JS, Lopes V, Robison K. Adherence patterns to National Comprehensive Cancer Network guidelines for referral of women with breast cancer to genetics professionals. Am J Clin Oncol. 2016;39:363\u20137.","journal-title":"Am J Clin Oncol."},{"key":"12595_CR7","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1200\/JCO.18.01854","volume":"37","author":"AW Kurian","year":"2019","unstructured":"Kurian AW, Ward KC, Howlader N, et al. Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol. 2019;37:1305\u201315.","journal-title":"J Clin Oncol."},{"key":"12595_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.18.01631","volume":"37","author":"PD Beitsch","year":"2019","unstructured":"Beitsch PD, Whitworth PW, Hughes K, et al. Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol. 2019;37:453\u201360.","journal-title":"J Clin Oncol."},{"key":"12595_CR9","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1245\/s10434-016-5328-7","volume":"23","author":"A Chiba","year":"2016","unstructured":"Chiba A, Hoskin TL, Hallberg EJ, et al. Impact that timing of genetic mutation diagnosis has on surgical decision-making and outcome for BRCA1\/BRCA2 mutation carriers with breast cancer. Ann Surg Oncol. 2016;23:3232\u20138.","journal-title":"Ann Surg Oncol."},{"key":"12595_CR10","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","volume":"384","author":"ANJ Tutt","year":"2021","unstructured":"Tutt ANJ, Garber JE, Kaufman B, et al. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. N Engl J Med. 2021;384:2394\u2013405.","journal-title":"N Engl J Med."},{"key":"12595_CR11","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1200\/JCO.2016.71.6480","volume":"35","author":"AW Kurian","year":"2017","unstructured":"Kurian AW, Li Y, Hamilton AS, et al. Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer. J Clin Oncol. 2017;35:2232\u20139.","journal-title":"J Clin Oncol."},{"key":"12595_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1245\/s10434-017-6190-y","volume":"24","author":"D Cragun","year":"2017","unstructured":"Cragun D, Vadaparampil S, Scherr C, Pal T. Comment on \u201cCan breast surgeons provide breast cancer genetic testing? An American Society of Breast Surgeons Survey.\u201d Ann Surg Oncol. 2017;24:588\u20139.","journal-title":"Ann Surg Oncol."},{"key":"12595_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1200\/JCO.18.01952","volume":"37","author":"KJ Milliron","year":"2019","unstructured":"Milliron KJ, Griggs JJ. Advances in genetic testing in patients with breast cancer, high-quality decision making, and responsible resource allocation. J Clin Oncol. 2019;37:445\u20137.","journal-title":"J Clin Oncol."},{"key":"12595_CR14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/jso.24763","volume":"116","author":"MR Wevers","year":"2017","unstructured":"Wevers MR, Aaronson NK, Bleiker EMA, et al. Rapid genetic counseling and testing in newly diagnosed breast cancer: patients\u2019 and health professionals\u2019 attitudes, experiences, and evaluation of effects on treatment decision making. J Surg Oncol. 2017;116:1029\u201339.","journal-title":"J Surg Oncol."},{"key":"12595_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1245\/s10434-016-5545-0","volume":"23","author":"AU Kishan","year":"2016","unstructured":"Kishan AU, Gomez CL, Dawson NA, et al. Increasing appropriate BRCA1\/2 mutation testing: the role of family history documentation and genetic counseling in a multidisciplinary clinic. Ann Surg Oncol. 2016;23:634\u201341.","journal-title":"Ann Surg Oncol."},{"key":"12595_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/gim.2016.130","volume":"19","author":"VF Quinn","year":"2017","unstructured":"Quinn VF, Meiser B, Kirk J, et al. Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial. Genet Med. 2017;19:448\u201356.","journal-title":"Genet Med."},{"key":"12595_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10549-017-4643-4","volume":"169","author":"HJ Pederson","year":"2018","unstructured":"Pederson HJ, Hussain N, Noss R, et al. Impact of an embedded genetic counselor on breast cancer treatment. Breast Cancer Res Treat. 2018;169:43\u20136.","journal-title":"Breast Cancer Res Treat."},{"key":"12595_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10549-022-06619-y","volume":"194","author":"SA Dettwyler","year":"2022","unstructured":"Dettwyler SA, Thull DL, McAuliffe PF, et al. Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy. Breast Cancer Res Treat. 2022;194:393\u2013401.","journal-title":"Breast Cancer Res Treat."},{"key":"12595_CR19","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1245\/s10434-021-09855-6","volume":"28","author":"KA Metcalfe","year":"2021","unstructured":"Metcalfe KA, Eisen A, Poll A, et al. Frequency of contralateral prophylactic mastectomy in breast cancer patients with a negative BRCA1 and BRCA2 rapid genetic test result. Ann Surg Oncol. 2021;28:4967\u201373. https:\/\/doi.org\/10.1245\/s10434-021-09855-6.","journal-title":"Ann Surg Oncol."},{"key":"12595_CR20","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1200\/JCO.2017.73.6314","volume":"35","author":"CP Childers","year":"2017","unstructured":"Childers CP, Childers KK, Maggard-Gibbons M, Macinko J. National estimates of genetic testing in women with a history of breast or ovarian cancer. J Clin Oncol. 2017;35:3800\u20136.","journal-title":"J Clin Oncol."},{"issue":"15","key":"12595_CR21","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1200\/JCO.20.02785","volume":"39","author":"AW Kurian","year":"2021","unstructured":"Kurian AW, Ward KC, Abrahamse P, et al. Time trends in receipt of germline genetic testing and results for women diagnosed with breast cancer or ovarian cancer, 2012\u20132019. J Clin Oncol. 2021;39(15):1631.","journal-title":"J Clin Oncol."},{"key":"12595_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1245\/s10434-020-09123-z","volume":"28","author":"JJ Alberty-Oller","year":"2021","unstructured":"Alberty-Oller JJ, Weltz S, Santos A, et al. Adherence to NCCN guidelines for genetic testing in breast cancer patients: who are we missing? Ann Surg Oncol. 2021;28:281\u20136.","journal-title":"Ann Surg Oncol."},{"key":"12595_CR23","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1002\/cncr.30621","volume":"123","author":"D Cragun","year":"2017","unstructured":"Cragun D, Weidner A, Lewis C, et al. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors. Cancer. 2017;123:2497\u2013505.","journal-title":"Cancer."},{"key":"12595_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11606-020-06064-x","volume":"36","author":"E Chapman-Davis","year":"2021","unstructured":"Chapman-Davis E, Zhou ZN, Fields JC, et al. Racial and ethnic disparities in genetic testing at a hereditary breast and ovarian cancer center. J Gen Intern Med. 2021;36:35\u201342.","journal-title":"J Gen Intern Med."},{"key":"12595_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/jgc4.1250","volume":"29","author":"JM Peterson","year":"2020","unstructured":"Peterson JM, Pepin A, Thomas R, et al. Racial disparities in breast cancer hereditary risk assessment referrals. J Genet Couns. 2020;29:587\u201393.","journal-title":"J Genet Couns."},{"key":"12595_CR26","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1200\/JCO.19.00160","volume":"37","author":"PS Rajagopal","year":"2019","unstructured":"Rajagopal PS, Catenacci DVT, Olopade OI. The time for mainstreaming germline testing for patients with breast cancer is now. J Clin Oncol. 2019;37:2177\u20138.","journal-title":"J Clin Oncol."},{"key":"12595_CR27","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s41431-021-00848-3","volume":"29","author":"C Beard","year":"2021","unstructured":"Beard C, Monohan K, Cicciarelli L, James PA. Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre. Eur J Hum Genet. 2021;29:872\u201380.","journal-title":"Eur J Hum Genet."},{"key":"12595_CR28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.4428","volume":"2","author":"Z Kemp","year":"2019","unstructured":"Kemp Z, Turnbull A, Yost S, et al. Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer. JAMA Netw Open. 2019;2:e194428.","journal-title":"JAMA Netw Open."},{"issue":"2","key":"12595_CR29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ygyno.2021.05.011","volume":"162","author":"J Lin","year":"2021","unstructured":"Lin J, Sharaf RN, Saganty R, et al. Achieving universal genetic assessment for women with ovarian cancer: are we there yet? A systematic review and meta-analysis. Gynecol Oncol. 2021;162(2):506\u201316.","journal-title":"Gynecol Oncol."},{"key":"12595_CR30","doi-asserted-by":"publisher","first-page":"e1982","DOI":"10.1002\/onco.13968","volume":"26","author":"EJ Walker","year":"2021","unstructured":"Walker EJ, Goldberg D, Gordon KM, et al. Implementation of an embedded in-clinic genetic testing station to optimize germline testing for patients with pancreatic adenocarcinoma. Oncologist. 2021;26:e1982\u201391.","journal-title":"Oncologist."},{"key":"12595_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41436-019-0705-9","volume":"22","author":"KE Wain","year":"2020","unstructured":"Wain KE, Azzariti DR, Goldstein JL, et al. Variant interpretation is a component of clinical practice among genetic counselors in multiple specialties. Genet Med. 2020;22:785\u201392.","journal-title":"Genet Med."},{"key":"12595_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/jgc4.1374","volume":"30","author":"JL Berliner","year":"2021","unstructured":"Berliner JL, Cummings SA, Boldt Burnett B, Ricker CN. Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes: practice resource of the National Society of Genetic Counselors. J Genet Couns. 2021;30:342\u201360.","journal-title":"J Genet Couns."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12595-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12595-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12595-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T17:04:03Z","timestamp":1672938243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12595-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["12595"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12595-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Irene Kang has accepted consulting fees and speaker bureau fees for Puma Biotechnology and consulting fees for Bristol Myers Squibb. Ketan Patel received textbook royalties from Elsevier. The remaining authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}